Company
Overview
Core Values
Executive Leadership
Services
Discovery & Preclinical
Pharmacology Services
Drug Safety Assessment
General Toxicology
Safety Pharmacology
Genetic Toxicology
Early Clinical Research (Phase 0 – IIa)
Phase 0-IIa
Bioequivalence Studies
Pharmacokinetics / Pharmacodynamics
Bioanalytical Services
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Validated Assays
Development & Regulatory Services
Drug Development
Biopharmaceutical Development
Regulatory Affairs
Program Management
Quality Assurance Services
Cardiac Safety Center of Excellence
List A-Z
List by Location
Locations
All Locations
Executive Offices
Discovery & Preclinical
Early Clinical Research
Bioanalytical Services
Scientific Library
Case Studies
Podcasts
Posters
Webinars
White Papers
Events
News
Contact Us
Study Participation
Medical Investigators
Careers at MDS
MDS Pharma Services News
September 30, 2009
MDS Pharma Services Earns ANVISA Certification to Support Entry to Fast-Growing Brazilian Pharmaceutical Market by Client Products
September 17, 2009
MDS Pharma Services to Host Global Scientific Symposia Series on Expediting Drug Discovery and Early Stage Development
Upcoming Events
December 2 2009 - December 4 2009
Barcelona, Spain
European Bioanalysis Forum
2003
MDS Pharma Services News Releases
MDS Pharma Services Acquires Early Clinical Research Facility in New Orleans
June 27, 2003
- MDS Pharma Services is expanding the scale and scope of its early clinical research business with its acquisition of The Clinical Research Center in New Orleans, Louisiana.
MDS Pharma Services Introduces Monoclonal Antibody Development Program
June 23, 2003
- MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, today announced the introduction of its new drug development program for therapeutic monoclonal antibodies, offered through the company's Drug Development Programs service.
MDS Pharma Services - St. Laurent facility resumes activity with approval of Canadian Nuclear Safety Commission
March 17, 2003
- MDS Pharma Services, a premier provider of innovative drug discovery and development solutions, has resumed business at the area where a minor incident involving a low-energy emitting isotope occurred.
MDS Pharma Services Establishing Bioanalytical Facility in the U.K.
February 24, 2003
- MDS Pharma Services has announced the expansion of its European bioanalytical capabilities with the development of its first bioanalytical facility in the United Kingdom.
Archives
2008
2007
2006
2005
2004
2003
2002
2001
© 2009 MDS Pharma Services |
Corporate Governance
|
Legal
|
Privacy
|
Site Map